473733-02-7

Basic information

• Product Name: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)
• Synonyms: 2-Furanmethanamine, a-ethyl-4-(1-methylethyl)-, (aR)-;(R)-1-(4-isopropylfuran-2-yl)propan-1-amine;a-ethyl-4-(1-Methylethyl)-;2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI);(1R)-1-(4-propan-2-ylfuran-2-yl)propan-1-amine
• CAS NO: 473733-02-7
• Molecular Formula: C₁₀H₁₇NO
• Molecular Weight: 167.25
• Product Categories: ISOPROPYL
• Mol File: 473733-02-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(473733-02-7)
• EPA Substance Registry System: 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI)(473733-02-7)

Safety Data

• Hazardous Substances Data: 473733-02-7(Hazardous Substances Data)

Usage

General Description

2-Furanmethanamine, alpha-ethyl-4-(1-methylethyl)-, (alphaR)-(9CI) is a chemical compound with the molecular formula C9H15NO. It is also known by its systematic name, (R)-2-ethyl-4-isopropyl-1-aminobutan-1-ol, and is classified as an amine. 2-Furanmethanamine,alpha-ethyl-4-(1-methylethyl)-,(alphaR)-(9CI) is a derivative of furan, with a butylamine substituent. It is primarily used in laboratory research and may have potential applications in pharmaceutical development and organic synthesis. The compound's specific properties and potential uses would depend on further study and testing.

Upstream product

• 59413-65-9 (4-isopropyl-furan-2-yl)-methanol 
• 946113-01-5 C₁₃H₂₁NO₂ 
• 811-49-4 ethyllithium 
• 38071-65-7 4-isopropyl-furan-2-carboxylic acid methyl ester 
• 101384-09-2 4-(1-Methyl-1-nitro-ethyl)-furan-2-carboxylic acid methyl ester 
• 1874-23-3 methyl 5-nitrofuran-2-carboxylate 
• 16015-07-9 4-Isopropyl-2-furaldehyde 

Downstream Products

• 681512-03-8 C₂₁H₂₇N₅O₄S 

Relevant articles and documents

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists

A novel series of cyclobutenedione centered C(4)-alkyl substituted furanyl analogs was developed as potent CXCR2 and CXCR1 antagonists. Compound 16 exhibits potent inhibitory activities against IL-8 binding to the receptors (CXCR2 Ki = 1 nM, IC50 = 1.3 nM; CXCR1 Ki = 3 nM, IC50 = 7.3 nM), and demonstrates potent inhibition against both Gro-α and IL-8 induced hPMN migration (chemotaxis: CXCR2 IC50 = 0.5 nM, CXCR1 IC50 = 37 nM). In addition, 16 has shown good oral pharmacokinetic profiles in rat, mouse, monkey, and dog.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.